Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.
about
Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectivesCetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy.Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in ratsAssessing physico-chemical compatibility of concomitantly diluted antiemetics including palonosetron-HCl and fosaprepitant dimeglumine.Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC).The Effects of the Bali Yoga Program for Breast Cancer Patients on Chemotherapy-Induced Nausea and Vomiting: Results of a Partially Randomized and Blinded Controlled Trial.
P2860
Q26744323-66D3A35D-5E39-48FE-91D2-7B0187649E1BQ35091386-BC2A10E0-1EB3-4845-98E6-EE94C9C3CEBDQ35248313-331FE661-0180-4325-A6CC-E698691EE4C2Q41950284-8BD71842-26F4-41EA-A0D1-30AE66F60C2AQ45354438-C978417B-88D5-49A7-B730-7348EDAFAA10Q46872839-BD0DD723-5C15-40F4-99A0-0FA972619338Q55010847-55DA29AC-21B7-444B-9F8C-45CD45BD87AA
P2860
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Safety, efficacy, and patient ...... y-induced nausea and vomiting.
@en
type
label
Safety, efficacy, and patient ...... y-induced nausea and vomiting.
@en
prefLabel
Safety, efficacy, and patient ...... y-induced nausea and vomiting.
@en
P2093
P2860
P356
P1476
Safety, efficacy, and patient ...... y-induced nausea and vomiting.
@en
P2093
Filippo De Braud
Francesca Ricchini
Luigi Celio
P2860
P304
P356
10.2147/PPA.S31288
P407
P577
2013-05-07T00:00:00Z